NCT03477565

Brief Summary

Over the last two decades in the field of oncology, the prevention, diagnosis, treatment and rehabilitation have reached a remarkable development, improving healing rates and reducing the number of deaths from cancer. The most frequent cancer in the female population is the breast one, which consequences can become disabling. In recent years, surgeons need to find more effective and less invasive treatments. Nowadays, despite the achievements, oncological surgery can cause side effects that cannot allow the return to normal life. Some of these problems are represented by the formation of edema and seroma, which can be handled by the physiotherapist through the manual lymphatic drainage and the application of an elastic tape. The elastic tape is used a lot in clinical practice, despite it lacks supportive evidence. The primary aim of the study is to verify the effectiveness of Kinesio Tex Tape in reducing edema and seroma formation following complex reconstructive breast surgery. The secondary goals are the evaluation of the quality of the scar, of the perception of pain, of the degree of satisfaction and disability. It is a controlled, monocentric, national, comparative, randomized, single-blind study. The sample size is 60 patients who undergo complex reconstructive breast surgery. Patients are divided into two groups: the experimental one (receiving standard treatment and Kinesio Tex Tape application) and a group of control (just receiving standard treatment). To evaluate edema and seroma, ultrasound is used; ultrasounds will be on the 1st, 15th and 30th postoperative days (T0, T1 and T2); Vancouver Scar Scale is used to define the quality of the scar (T0 and T2); to measure the subjective perception of pain and to evaluate the degree of patient satisfaction, two VAS scales are administered (the VAS scale for pain is administered at T0, T1 and T2, while the VAS scale for satisfaction is given at T1 and T2); Finally, to assess the degree of disability, the DASH Questionnaire is used (T0, T1 and T2).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable breast-cancer

Timeline
Completed

Started Apr 2018

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 17, 2018

Completed
1 month until next milestone

First Posted

Study publicly available on registry

March 26, 2018

Completed
8 days until next milestone

Study Start

First participant enrolled

April 3, 2018

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2020

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2020

Completed
Last Updated

March 26, 2018

Status Verified

March 1, 2018

Enrollment Period

2 years

First QC Date

February 17, 2018

Last Update Submit

March 19, 2018

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change in edema quantity at 30th postoperative day

    Quantity of edema is measured in millimetres, through ultrasound scan. The verification of the effectiveness of elastic tape in terms of reduction of edema will be performed through ultrasound. During the ultrasound acquisition patients are indicated to assume the supine position on the couch, with 45 ° of humerus flexion and abduction, supported by an operator . Five points of maximum thickness of skin and subcutaneous tissue (edema) will be detected : retroareolar space, Upper-outer quadrant, Upper-inner quadrant, Lower-outer quadrant and Lower-inner quadrant. The thickness will be measured in millimeters.

    The measurement is assessed at 1st, 15th and 30th post-operative days.

  • Change in seroma quantity at 30th postoperative day

    Quantity of seroma is measured in millimetres, through ultrasound scan. The verification of the effectiveness of elastic tape in terms of resolution of seroma will be performed through ultrasound. During the ultrasound acquisition patients are indicated to assume the supine position on the couch, with 45 ° of humerus flexion and abduction, supported by an operator . Five points of maximum thickness of liquid (seroma) will be detected : retroareolar space, Upper-outer quadrant, Upper-inner quadrant, Lower-outer quadrant and Lower-inner quadrant. The thickness will be measured in millimeters.

    The measurement is assessed at 15th and 30th post-operative days.

Secondary Outcomes (4)

  • Quality of the scar

    The measurement is assessed at 1st and 30th post-operative days.

  • Subjective perception of pain

    The measurement is assessed at 1st,15th and 30th post-operative days.

  • Degree of patient satisfaction

    The measurement is assessed at 15th and 30th post-operative days.

  • Degree of disability

    The measurement is assessed at 1st, 15th and 30th post-operative days.

Study Arms (2)

Sperimental group

EXPERIMENTAL

Patients who belong to the sperimental group ("SPER") will receive the standard treatment and Kinesio tape lymphatic drainage technique application. The experimental group also receives the expected standard treatment, consisting in physiotherapeutic evaluation and physiotherapy counseling.

Device: Kinesio tape lymphatic drainage technique application

Control group

NO INTERVENTION

Patients who belong to the control group ("CONTR") will receive only the standard treatment. Standard treatment consists in physiotherapy evaluation and counseling. The educational part, the demonstration of the exercises and the prosthesis mobilization are included in this treatment.

Interventions

Kinesio Tex Tape strips are applied following Dr.Kase draining techinique. The choice of tape's length and strips' number is based on the area of breast edema and/or presence of seroma, which must be completely covered. The patch is cut into fan strips. The major base is positioned near the functioning lymph node stations closest to the edema and/or seroma area. The bases and the tails of the fan must be applied with zero tension, while for the central part is reached 15-25% of tension. The first application takes place on the 1st post-operative day, while the second is performed on the 7th post-operative day. In case the tape is detached from one application to another, it is necessary that the patient resume in the clinic for a new application to ensure continuity of the therapeutic effect; otherwise the patient is eliminated from the study. The experimental group also receives the expected standard treatment, consisting in physiotherapeutic evaluation and counselin.

Also known as: Kinesio Tape, Kinesiotape, Kinesio Tapes, Kinesio Taping, Kinesiology Taping
Sperimental group

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Female patients aged ≥ 18;
  • Complex reconstructive breast surgery with expander or prosthesis;
  • Conditions favoring the correct execution of the proposed program (ability to complete the questionnaires);
  • Written informed consent adherence.

You may not qualify if:

  • Patients with psychic or other disorders that may prevent the completion of the questionnaires and / or informed consent adherence;
  • Deferred breast reconstruction;
  • Bilateral breast surgery reconstruction;
  • Previous laterocervical emptying surgery;
  • Maintenance of the surgical drainage for more than 8 days;
  • Acute infections in other parts of the body.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IRCCSSRaffaele

Milan, 20132, Italy

Location

MeSH Terms

Conditions

Breast NeoplasmsEdemaSeroma

Interventions

Athletic Tape

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsInflammationPathologic Processes

Intervention Hierarchy (Ancestors)

BandagesEquipment and SuppliesOrthotic DevicesOrthopedic EquipmentSurgical Equipment

Study Officials

  • Stefano Martella

    IRCCS San Raffaele

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Stefano Martella

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Primary Doctor of General Reconstructive Surgery Operating Unit.

Study Record Dates

First Submitted

February 17, 2018

First Posted

March 26, 2018

Study Start

April 3, 2018

Primary Completion

April 1, 2020

Study Completion

July 1, 2020

Last Updated

March 26, 2018

Record last verified: 2018-03

Locations